Active ingredientCyclopentolate HydrochlorideCat. No. P-C270-001CAS 5870-29-1Family · Pharmaceutical analytical standards
Cyclopentolate
An anticholinergic synthesised in 1952 as an analogue of atropine: as an eye drop it dilates the pupil and blocks focusing for some hours (cycloplegia), and it is widely used in children's eye examinations. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It is often chosen as a shorter-acting alternative to atropine, which lasts much longer: pupil dilation lasts up to about 24 hours and the loss of focusing from 6 to 24 hours.
Go to the active ingredient →Active ingredientCyclopentolate HydrochlorideCat. No. P-C270-001CAS 5870-29-1
Pharmacopoeial impurityCyclopentolate EP Impurity ACat. No. P-C270-002CAS 25209-52-3
Pharmacopoeial impurityCyclopentolate EP Impurity C HydrochlorideCat. No. P-C270-003CAS 113079-81-5
ImpurityCyclopentolate Impurity 1Cat. No. P-C270-004
ImpurityCyclopentolate N-OxideCat. No. P-C270-005CAS 2724726-91-2
ImpurityCyclopentolate N-Oxide HydrochlorideCat. No. P-C270-006CAS 2724726-92-3
ImpurityCyclopentylideneacetonitrileCat. No. P-C270-007CAS 5732-88-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceCyclopentolate hydrochloride CRSEDQM code C3245000Family CyclopentolateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.